Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous cell therapy for shoulder osteoarthritis
NCT02844738Phase 2Recruiting
- Sponsor
- VivaTech
- Start
- Jul 2015
- Primary completion
- Aug 2026
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of StroMed in osteoarthritis (OA), sponsored by VivaTech. Started Jul 2015; status: recruiting.
02
Drugs
StroMed
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02844738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02844738.